Phase 4 Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT06625450 Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 4 Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT06625450
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with ulcerative colitis (a type of bowel disease), confirmed by camera examination of the bowel and tissue samples.
  • People whose ulcerative colitis has been in remission (no active symptoms) for at least 3 months while taking two medications: Tofacitinib and mesalamine.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose medical evaluation or records are incomplete.
  • People whose diagnosis is uncertain or unclear.
  • People who currently have active disease symptoms.
  • People who have been diagnosed with Crohn's disease, microscopic colitis, collagenous colitis, or an unclassified form of inflammatory bowel disease.
  • People who are unwilling to take part in the study.
  • Women who are pregnant, breastfeeding, or planning to become pregnant within the next 2 years.
  • People who have a suspected or confirmed cancer of any kind.
  • People who have serious other health conditions (confirm with trial site).
  • People who have previously had a blood clot in a vein (such as a clot in the leg or lung).
  • People who are currently having major surgery.
  • People who have had a heart attack within the past 3 months.
  • People who have heart failure.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +917798152446

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Time to relapse of colitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov